Net Worth Advisory Group’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$893K Sell
15,492
-1,113
-7% -$63.9K 0.22% 95
2026
Q1
$1.01M Sell
16,605
-244
-1% -$14.2K 0.21% 93
2025
Q4
$909K Buy
+16,849
New +$811K 0.18% 100

Other funds holding BMY

Net Worth Advisory Group's BMY Position: Q2 2026 in Review

Net Worth Advisory Group reduced its Bristol-Myers Squibb (BMY) stake by 6.7% in Q2 2026, selling an estimated $63.9K and leaving 15,492 shares worth $893K. The position accounts for 0.22% of the portfolio, ranked #95.

Net Worth Advisory Group first reported a position in BMY in Q4 2025 and has held it in 3 quarters since. The position peaked at $1.01M in Q1 2026. 498 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

  • Net Worth Advisory Group held 15,492 shares of Bristol-Myers Squibb worth $893K as of Q2 2026.
  • Net Worth Advisory Group sold 1,113 Bristol-Myers Squibb shares in Q2 2026, an estimated $63.9K.
  • Bristol-Myers Squibb made up 0.22% of Net Worth Advisory Group's portfolio in Q2 2026, its #95 holding.
  • Net Worth Advisory Group first reported a position in Bristol-Myers Squibb in Q4 2025 and has held it in 3 quarters since.
  • Net Worth Advisory Group's Bristol-Myers Squibb position peaked at $1.01M in Q1 2026.
  • 498 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on Net Worth Advisory Group's 13F filing for Q2 2026, filed 14 Jul 2026.